Anzeige
Mehr »
Samstag, 29.11.2025 - Börsentäglich über 12.000 News
MONSTER VON MAROKKO: AYA liefert die stärksten Bohrergebnisse seiner Geschichte - und dieser 3-Mrd-Dollar-Silberproduzent steigt jetzt in eine neue Liga auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14.11.Sanofi's type 1 diabetes drug poised for EU rollout
14.11.Lundbeck makes bid for Avadel, trying to displace Alkermes
14.11.Kura scores FDA okay for rival to Syndax's leukaemia drug
14.11.Update: MSD's $9.2bn deal for flu biotech Cidara confirmed
14.11.Medicxi raises €500m for latest biotech fund
14.11.Medicxi raises €500m for fifth biotech fund
14.11.MSD said to be close to $9bn+ deal for flu biotech Cidara
13.11.NICE backs Roche's non-Hodgkin lymphoma drug Columvi
13.11.AbbVie exits alliance with Alphabet biotech Calico; report
13.11.Novartis says novel drug could counter malaria resistance
13.11.FDA unveils swift route to market for personalised drugs
13.11.Change at the top of Recursion as co-founder leaves CEO role
12.11.One Drop founder announces broad market CGM on Frontiers stage
12.11.Alkermes breaks new ground in narcolepsy with orexin drug
12.11.Bayer beats expectations with tougher times looming
12.11.AI features in UK plan to reduce animal testing
12.11.NHS braces for thousands of redundancies
12.11.FDA appoints veteran Pazdur to replace Tidmarsh
11.11.Trial sets up filing for enGene bladder cancer gene therapy
11.11.Daiichi Sankyo launches its STING operation against cancer
11.11.Ireland's Mallinckrodt closes spinout, rebrands as Keenova
11.11.Queer Eye's Tan France to front Lilly obesity campaign
11.11.AHA: MSD's oral PCSK9 matches injectables
10.11.Roche's oral MS hope fenebrutinib hits the mark in phase 3
10.11.AHA: AZ's baxdrostat impresses in resistant hypertension